TGFB1 and neoplasm: Treatment of non-quiescent fibroblasts with TGF-β, a key regulator of tumor microenvironment signaling pathways [15] and a driver of fibrotic ECM deposition [16], was previously shown to induce QSOX1 transcription [6].